The setup is “manufacturing bottleneck leverage”: Fabrinet is already
qualified at the hardest optical steps, so incremental demand tends to land with incumbents that can hit
yield/quality quickly. The 5-year upside is less about inventing a new product and more about (1) scaling capacity without breaking quality, (2) moving up the value stack into more complex packaging/test, and (3) using automation/software to protect margins while volumes rise. The check is valuation: today’s premium only works if execution stays clean through the next cycle.